Meet The Chinese Company That Wants To Be The Intel Of Personalized Medicine

In 1999, the first fully sequenced human genome cost roughly $3 billion to complete. By 2007, the cost had decreased to a couple of million dollars, and today it is around $1,000. BGI, a Shenzhen-based company, thinks it can drive the cost down to $200.

Its confidence is not misplaced. BGI has already invested hundreds of millions of dollars, and is at the forefront of a technology revolution known as Next Generation Sequencing (NextGen), which allows genomics testing to be done at a scale and speed that was previously impossible.

Back to news